EUVIMEDEUVIMED entdecken
Crossref

Tracheobronchial Amyloidosis: Clinical Experience From 2018 to 2023 at a National Respiratory Centre

Lynn Yim-Wah Shong iD, Guo-Wu Zhou, Run Tong, Ming-Ming Deng, Ling Zhao, Zhi-Ping Fan, Zi-Wen Zheng, Jia Li, David Chi-Leung Lam, Gang Hou iD

Respirology · 2026

DOI: 10.1002/resp.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology, 2026. Verfasst von Lynn Yim-Wah Shong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen Mary Hospital, Hong Kong, China. Hauptthemen laut MEDLINE: Amyloidosis, Bronchial Diseases, Tracheal Diseases. Die Arbeit nennt 33 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, Excellence & Innovation Initiative of China-Japan Friendship Hospital, National High-Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Tracheobronchial amyloidosis is a rare disease. This study aimed to assess the clinical presentation, radiological findings, bronchoscopic features, pathological findings and management approach at a national respiratory centre in China.

Methods

We retrospectively analysed biopsy‐confirmed tracheobronchial amyloidosis cases from 2018 to 2023 using electronic medical records. Data on demographics, clinical manifestations, investigational findings, management and prognosis were analysed.

Results

Six patients (2 women and 4 men, mean age 55.5 years) were diagnosed with tracheobronchial amyloidosis. Common symptoms included cough, sputum and dyspnoea. None of the patients had evidence of extra‐pulmonary amyloidosis. Diagnosis was confirmed via tracheobronchial biopsy. Precursor proteins included AL‐λ and AL‐κ in 2 patients, AL‐κ and ATTR in one patient. The median delay from symptoms onset to diagnosis was 18 months while computerised tomography (CT) imaging expediated diagnosis of tracheobronchial amyloidosis, with a median time from CT thorax to diagnostic bronchoscopy of 2 days in four cases, with two cases lacking detailed information on the date of the initial CT. Treatments included bronchoscopic intervention in three patients and observation in three patients.

Conclusions

Patients with tracheobronchial amyloidosis often present with symptoms resembling those of other airway disorders. Considering this condition in differential diagnosis is crucial when standard treatments fail. Chest CT facilitates prompt referral for diagnostic bronchoscopy. No curative therapy is currently available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisBronchial DiseasesTracheal DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesBronchoscopyAgedTomography, X-Ray ComputedAdultChinaBiopsy

Stichwörter der Autor:innen

bronchoscopycomputed tomographylung diseaseprecursor proteinstracheobronchial amyloidosis

Autor:innen und Institutionen

  • Department of Medicine, Queen Mary Hospital, Hong Kong, China.
  • Department of Pulmonary and Critical Care Medicine, Centre of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
  • Department of Pathology, China-Japan Friendship Hospital, Beijing, China.
  • Department of Medicine, The University of Hong Kong, Hong Kong, China.

ORCID-Profile: Lynn Yim-Wah Shong, Gang Hou

Förderung

  • CAMS Innovation Fund for Medical Sciences
  • Excellence & Innovation Initiative of China-Japan Friendship Hospital
  • National High-Level Hospital Clinical Research Funding

Zitieren

APA

Shong, L. Y., Zhou, G. W., Tong, R., Deng, M. M., Zhao, L., Fan, Z. P., Zheng, Z. W., Li, J., Lam, D. C., & Hou, G. (2026). Tracheobronchial Amyloidosis: Clinical Experience From 2018 to 2023 at a National Respiratory Centre. Respirology. https://doi.org/10.1002/resp.70144

Vancouver

Shong LY, Zhou GW, Tong R, Deng MM, Zhao L, Fan ZP, et al. Tracheobronchial Amyloidosis: Clinical Experience From 2018 to 2023 at a National Respiratory Centre. Respirology. 2026. doi:10.1002/resp.70144

BibTeX
@article{Shong2026,
  author = {Shong, Lynn Yim-Wah and Zhou, Guo-Wu and Tong, Run and Deng, Ming-Ming and Zhao, Ling and Fan, Zhi-Ping and Zheng, Zi-Wen and Li, Jia and Lam, David Chi-Leung and Hou, Gang},
  title = {Tracheobronchial Amyloidosis: Clinical Experience From 2018 to 2023 at a National Respiratory Centre},
  journal = {Respirology},
  year = {2026},
  doi = {10.1002/resp.70144}
}
Kostenlos starten →